Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90
Published February 8, 2017 · Recall initiated: December 29, 2016
Summary
FDA records drug Class III recall D-0453-2017, published February 8, 2017 and initiated December 29, 2016. Recalling firm: Hetero Drugs Ltd. - Unit 1; Status: Terminated; Reported quantity: 20,412 units; Lot: Lot #: FIN16002, Exp. 03/2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
What to do
Voluntary: Firm initiated · Letter
Get an email if FINASTERIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FINASTERIDE
- Manufacturer
- Hetero Drugs Ltd. - Unit 1
- Distributor
- NJ only.
- UPC
- 0331722525305
- Lot
- Lot #: FIN16002, Exp. 03/2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAFinasteride Tablets USP, 5 mg, Rx Only, Packaged as: a) 30-count bottles NDC 16729-090-10 UPC 3 16729 09010 0;March 8, 2023
- FDAFinasteride Tablets USP, 1 mg, Rx Only, Packaged as: a) 30-count bottle NDC 16729-089-10 UPC 3 16729 08910 4;March 8, 2023
- FDAFlucanozole Tablets, USP, 200 mg, a) 30 count (NDC 55111-146-30) and b) 100 count (NDC 55111-146-01) bottles,February 8, 2017
- FDAEndure 400 Scrub-Stat (chlorhexidine gluconate) Foam Forming Solution, 4%, packaged in plastic (HDPE) bottles,February 8, 2017
- FDAFlucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, BachupallyFebruary 8, 2017
- FDASun Pharma Carbidopa and Levodopa Tablets USP 25 mg/250 mg a) 100-count bottles (NDC 62756-519-88), b)February 8, 2017
Questions about this recall
Was Finasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals, Inc. Piscataway, NJ 08854 By: Hetero Hetero Labs, Unit V Polepally, Jadcheria, Mahaboob Nagar - 509 301, India Limited NDC 31722-525-90 recalled?
Yes. FDA published recall D-0453-2017 on February 8, 2017. Reported hazard: Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FINASTERIDE. UPC: 0331722525305.